The transcription factor NF-E2-related factor 2 (Nrf2) regulates the expression of several cytoprotective genes and is a promising target for the treatment of chronic, oxidative stress–related disorders, such as neurodegenerative diseases and chronic kidney disease [1–3]. The gene discussed is NFE2L2; the disease is neurodegenerative disease.